Back to Results
First PageMeta Content
Protease inhibitors / Immunology / Pyrazines / Telaprevir / Boceprevir / Ribavirin / Interferon / Peginterferon alfa-2a / Cirrhosis / Antivirals / Medicine / Pharmacology


Document Date: 2012-12-12 10:43:38

Open Document

File Size: 89,28 KB

Share Result on Facebook

City

Créteil / BOSTON / /

Company

Merck / ANRS / /

Country

France / /

Event

Person Communication and Meetings / Judicial Event / /

Facility

French National Institute / /

MedicalCondition

septicemia / septic shock / neutropenia / cirrhosis / thrombocytopenia / HCV / severe anemia / virus infections / difficult‐to‐manage anemia / severe infection / compensated cirrhosis / endocarditis / Viral Hepatitis / greater anemia / renal failure / esophageal varices / infections / hepatic decompensation / anemia / chronic hepatitis C / /

MedicalTreatment

blood transfusion / /

Organization

American Association for the Study of Liver Diseases / French National Agency for Research / French National Institute for Health and Medical Research / /

Person

NEIL OSTERWEIL / Christophe Hézode / /

Position

speaker and adviser / /

Product

ribavirin / Pegasys / PegIntron / /

SocialTag